BRUNO LOZANO: Open Payments
NPI 1821725466 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 47 payments from 9 companies in 2025. Trend: 2023 $409 · 2024 $446 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $325 |
| Boston Scientific Corporation | 24 | $255 |
| CVRx, Inc. | 2 | $181 |
| PFIZER INC. | 4 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Medtronic, Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: CAMZYOS, Barostim Neo System, CDS - MCT/CEM Monitoring, CDS - Other, ELIQUIS, JARDIANCE, LINQ II, Kerendia.
Industry payments across TX — which companies pay providers there.
